The future of Pharma R&D

R&D has traditionally been and will continue to be (probably even more) crucial for the growth and future success of research-based pharma companies. The pharmaceutical industry has now entered a period of significant uncertainty and transition characterized by higher R&D costs, depleted pipelines and financial restriction to perform innovative research. The global credit crunch exacerbates all this with more and more layoffs and research budget cuts, but major crisis can sometimes produce major opportunities. 


    Related Conference of The future of Pharma R&D

    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands

    The future of Pharma R&D Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in